Anti-IL12 imposes the death sentence on Th1 cells in TNBS colitis--is there a light at the end of the tunnel for Crohn's disease?
Mullin
G E
GE
Department of Medicine, North Shore University Hospital, Manhasset, New York, USA.
Galinkin
D
D
D000818:Animals; D000906:Antibodies; D017209:Apoptosis; D003424:Crohn Disease / Q000276:immunology / Q000473:pathology*; D004195:Disease Models, Animal; D006801:Humans; D007249:Inflammation; D018664:Interleukin-12 / Q000276:immunology*; D051379:Mice; D006377:T-Lymphocytes, Helper-Inducer; D014302:Trinitrobenzenesulfonic Acid / Q000008:administration & dosage / Q000009:adverse effects
D000906:Antibodies; D018664:Interleukin-12; D014302:Trinitrobenzenesulfonic Acid